YouTube Facebook LinkedIn Google+ Twitter Xinginstagram rss  

Complete Genomics and China's Ulterior Motives

December 13, 2012 | Michael Wessel and Larry Wortzel, congressionally-appointed members of the U.S.-China Economic and Security Review Commission, recommend the utmost scrutiny of the BGI-Complete Genomics deal. It's not just future genomic medicine that's at stake, but "the building blocks of 21st-century bioweapons." Mercury News
Click here to login and leave a comment.  


Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact Angela Parsons, 781.972.5467.